Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03078231 · ClinicalTrials.gov registry record
Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
A clinical trial, sponsored by Eyenuk.
- Completed
- Registry status
- 52
- Enrollment target
NCT03078231 is a clinical trial that has completed, run by Eyenuk. The registered enrollment target is 52 participants.
The verdict
NCT03078231 has completed, sponsored by Eyenuk.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
More than 29 million people in the US are living with diabetes, many of whom will develop diabetic retinopathy (DR) or diabetic eye disease (DED), the leading cause of vision loss and blindness in working-age adults. Annual eye screening is recommended for all diabetic patients since vision loss can be prevented with laser photocoagulation and anti-VEGF injections if DR is diagnosed in its early stages. Currently, the number of clinical personnel trained for DR screening is orders of magnitude smaller than that needed to screen the large, growing diabetic population. Therefore, to meet this large unmet need for DR screening, a fully-automated computerized DR screening system is necessary. This study is designed to assess the performance of EyeArt, an automated DR screening tool.
Interventions
- PROCEDURE Color fundus photography
- DRUG Mydriatic Agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2017-04-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03078231
The ClinicalTrials.gov registry entry for NCT03078231 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eyenuk, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Color fundus photography is the first listed.
NCT03078231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03078231 about?
NCT03078231 is a clinical study titled "Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool". More than 29 million people in the US are living with diabetes, many of whom will develop diabetic retinopathy (DR) or diabetic eye disease (DED), the leading cause of vision loss and blindness in working-age adults. Annual eye screening is recommended for all diabetic patients since vision loss can...
What is the current status of trial NCT03078231?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2017-02-17. Estimated completion is 2017-04-24.
What interventions are being tested in trial NCT03078231?
The interventions under investigation include: Color fundus photography (PROCEDURE), Mydriatic Agent (DRUG).
Who is sponsoring clinical trial NCT03078231?
This trial is sponsored by Eyenuk, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.